(Q35762456)

10 August 2017

1 reference

title

C/EBPalpha mutations in acute myeloid leukaemias (English)

1 reference

10 August 2017

1 reference

Claus Nerlov

1

1 reference

PubMed ID

15122210

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

10 August 2017

Nature Reviews Cancer

1 reference

10 August 2017

4

1 reference

10 August 2017

394-400

1 reference

10 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1363

10 August 2017

0 references

cites work

Disruption of differentiation in human cancer: AML shows the way.

1 reference

Impaired energy homeostasis in C/EBP alpha knockout mice

31 March 2020

1 reference

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice

31 March 2020

1 reference

Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells

31 March 2020

1 reference

CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors

31 March 2020

1 reference

Distinct C/EBP functions are required for eosinophil lineage commitment and maturation

31 March 2020

1 reference

A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity

31 March 2020

1 reference

Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc

31 March 2020

1 reference

The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells.

31 March 2020

1 reference

Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap

31 March 2020

1 reference

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

31 March 2020

1 reference

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias

31 March 2020

1 reference

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

31 March 2020

1 reference

Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.

31 March 2020

1 reference

The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML.

31 March 2020

1 reference

Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.

31 March 2020

1 reference

Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.

31 March 2020

1 reference

AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

31 March 2020

1 reference

Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias

31 March 2020

1 reference

BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.

31 March 2020

1 reference

CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells

31 March 2020

1 reference

Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes.

31 March 2020

1 reference

Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1.

31 March 2020

1 reference

CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation

31 March 2020

1 reference

Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity

31 March 2020

1 reference

Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation

31 March 2020

1 reference

CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter

31 March 2020

1 reference

Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions

31 March 2020

1 reference

CCAAT-enhancer binding protein: a component of a differentiation switch

31 March 2020

1 reference

Separation of C/EBPalpha-mediated proliferation arrest and differentiation pathways.

31 March 2020

1 reference

CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice

31 March 2020

1 reference

C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4

31 March 2020

1 reference

The Rb/E2F pathway: expanding roles and emerging paradigms

31 March 2020

1 reference

C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription

31 March 2020

1 reference

E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo

31 March 2020

1 reference

c-Myc is a critical target for c/EBPalpha in granulopoiesis.

31 March 2020

1 reference

Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen

31 March 2020

1 reference

Cell cycle inhibition mediated by the outer surface of the C/EBPα basic region is required but not sufficient for granulopoiesis

31 March 2020

1 reference

The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest

31 March 2020

1 reference

Rb-mediated chromatin structure regulation and transcriptional repression

31 March 2020

1 reference

The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow

31 March 2020

1 reference

C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.

31 March 2020

1 reference

C/EBPepsilon interacts with retinoblastoma and E2F1 during granulopoiesis

31 March 2020

1 reference

C/EBPepsilon -/- mice: increased rate of myeloid proliferation and apoptosis

31 March 2020

1 reference

Expression of C/EBPbeta from the C/ebpalpha gene locus is sufficient for normal hematopoiesis in vivo.

31 March 2020

1 reference

CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia

31 March 2020

1 reference

CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein

31 March 2020

1 reference

C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice

31 March 2020

1 reference

Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest.

31 March 2020

1 reference

Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase

31 March 2020

1 reference

Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1363

1 reference

10 August 2017

1 reference

PubMed ID

15122210